6 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $3M | -$11M | 40.8% | -348.7% | -$10M | — | $1M |
| 2024 | $3M | -$10M | 45.8% | -330.5% | -$10M | — | $6M |
| 2023 | $1M | -$11M | 26.0% | -1002.1% | — | — | $2M |
| 2022 | $437146 | -$8M | 0.0% | -1907.1% | — | — | $8M |
| 2021 | $2M | -$7M | 0.0% | -281.4% | — | — | $13M |
| 2020 | — | -$3M | — | — | — | — | $427273 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $1M | -$3M | 50.5% | -277.8% | -$4M | — | $7M |
| Dec '25 | $896774 | -$3M | 51.3% | -293.9% | -$2M | — | $740371 |
| Sep '25 | $1M | -$3M | 46.6% | -269.8% | -$3M | — | $2M |
| Jun '25 | $843884 | -$3M | 39.8% | -367.5% | — | — | $1M |
| Mar '25 | $728867 | -$3M | 46.8% | -351.3% | — | — | $3M |
| Dec '24 | $607494 | -$2M | 36.7% | -372.8% | — | — | $2M |
| Sep '24 | $872287 | -$3M | 39.8% | -312.4% | — | — | $4M |
| Jun '24 | $727824 | -$3M | 112.1% | -386.3% | — | — | $6M |
| Mar '24 | $823800 | -$3M | 21.7% | -358.6% | — | — | $9M |
| Dec '23 | $764063 | -$2M | 26.1% | -260.6% | — | — | $1M |
| Sep '23 | $796094 | -$2M | 29.2% | -317.3% | — | — | $186401 |
| Jun '23 | $443135 | -$3M | 11.2% | -609.9% | — | — | $2M |
| Mar '23 | $457058 | -$6M | 7.2% | -1431.6% | — | — | $2M |
| Dec '22 | $356679 | -$420600 | 68.4% | -597.4% | — | — | $3M |
| Sep '22 | $311320 | -$1M | 0.0% | -391.4% | — | — | $6M |
| Jun '22 | $66855 | -$2M | 0.0% | -3123.3% | — | — | $8M |
| Mar '22 | $192500 | -$1M | 0.0% | -697.6% | — | — | $11M |
| Dec '21 | — | -$3M | — | — | — | — | $11M |
| Sep '21 | — | -$1M | — | — | — | — | $13M |
| Jun '21 | $2M | -$852999 | 0.0% | -53.0% | — | — | $13M |
How the market has priced INBS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, INTELLIGENT BIO SOLUTIONS INC.'s revenue has grown 11.4% per year. These are computed facts, not advice.
As of FY2025, INTELLIGENT BIO SOLUTIONS INC. reported — of total debt against $1M of cash; operating income covered interest expense -174.8×.
In FY2025, gross margin was 40.8%, operating margin -348.7%, and net margin -346.2%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.